Blood Gas Monitoring Systems
Arterial blood gases are the most commonly ordered test in critical care settings such as ICUs and ORs.Tests with rapid turnaround times, such as POC tests, are largely replacing the slower laboratory test market. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the markets for POC and laboratory blood gas analyzers, arterial blood gas sampling kits, pulse oximeters, and capnography/end-tidal CO2 monitoring products for the US, the five major EU markets, Japan, and rest of world markets. The combined global market for blood gas monitoring products totaled approximately $3.6bn in 2018. Total sales are expected to increase at a CAGR of 6.1%, reaching an estimated $4.9bn in 2023. Pulse oximeters and POC blood gas analyzers combined accounted for more than 85% of the total market, with $3.1bn. Five companies account for more than 80% of the total market: Medtronic, Masimo, Abbott, Radiometer, and Siemens.